IP Library Granted Patent US 8,219,201
Granted Patent B2
US 8,219,201 · App. 11/736,183 · Granted Jul 10, 2012

Smooth muscle controller for controlling the level of a chemical in the blood stream

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,219,201
App. No.
11/736,183
Granted
Jul 10, 2012
Kind
B2
Abstract

An apparatus that comprises at least one electrode adapted to be placed adjacent to a portion of smooth muscle ( 200 ) and a controller for electrifying the electrode with a non-excitatory electric field ( 210 ) which does not generate excitation of the smooth muscle. The non-excitatory electric field affects the activity of the smooth muscle in a manner that controls a level of a chemical in the blood stream.

Claims (28)

1. Apparatus comprising:

at least one implantable electrode adapted to be placed adjacent to a portion of smooth muscle; and

a controller for electrifying said implantable electrode with a non-excitatory electric field which does not generate excitation of said smooth muscle, wherein said non-excitatory electric field affects the activity of said smooth muscle in a manner that controls a level of a chemical in the blood stream.

2. The apparatus according to claim 1 , comprising a sensor for measuring a level of said chemical in a blood stream.

3. The apparatus according to claim 2 , wherein said controller electrifies said implantable electrode with said non-excitatory electric field, responsive to the measured level.

4. The apparatus according to claim 3 , wherein said chemical is glucose.

5. The apparatus according claim 1 , wherein said chemical is a hormone.

6. The apparatus according to claim 5 , wherein said hormone is insulin.

7. The apparatus according to claim 1 , wherein said chemical is glucose.

8. The apparatus according to claim 1 , wherein said at least one implantable electrode is configured to be located in the GI tract.

9. The apparatus according to claim 8 , wherein said at least one implantable electrode is configured to be located on the stomach.

10. The apparatus according to claim 1 , wherein said implantable electrode is configured to be located adjacent to the pancreas.

11. A method for controlling the level of a chemical in the blood of a patient, comprising:

implanting at least one electrode adjacent to a portion of smooth muscle or a of said patient; and

electrifying said electrode with a non-excitatory electric field which does not generate excitation of said smooth muscle, wherein said non-excitatory electric field affects the activity of said smooth muscle in thereby controlling the level of said chemical in the patient's blood stream.

12. The method according to claim 11 , comprising measuring a level of said chemical in a blood stream.

13. The method according to claim 12 , wherein electrifying said electrode with said non-excitatory electric field is responsive to the measured level.

14. The method according to claim 13 , wherein said chemical is glucose.

15. The method according to claim 11 , wherein said chemical is a hormone.

16. The method according to claim 15 , wherein said hormone is insulin.

17. The method according to claim 11 , wherein said chemical is glucose.

18. The method according to claim 11 , wherein said at least one electrode is located in the GI tract.

19. The method according to claim 11 , said electrode is adjacent to the pancreas.

20. The method according to claim 11 , wherein said at least one electrode is located inside the body of the patient and outside a portion of the GI tract.

21. A method for controlling the level of a chemical in the blood of a patient, comprising:

placing at least one electrode adjacent to a portion of smooth muscle or a gland of said patient; and

electrifying said electrode with a non-excitatory electric field which does not generate excitation of said smooth muscle or gland, wherein said non-excitatory electric field affects the activity of said smooth muscle or gland in thereby controlling the level of said chemical in the patient's blood stream,

wherein said at least one electrode is located in the GI tract on the stomach.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2019
From: METACURE LIMITED
To: TYLERTON INTERNATIONAL, INC.
Reel/Frame 051391/0676 →
ASSIGNMENT OF TRADEMARK AND PATENT SECURITY AGREEMENT Recorded Apr 8, 2015
From: MEDINVEST CAPITAL S.A.R.L.; MORGAN STANLEY BANK INTERNATIONAL LIMITED
To: SANDLEFORD PARK LIMITED, AS SECURITY AGENT
Reel/Frame 035387/0041 →
SECURITY AGREEMENT Recorded Aug 3, 2009
From: MOTORIKA LIMITED
To: MORGAN STANLEY BANK INTERNATIONAL LIMITED; MEDINVEST CAPITAL S.A R.L.
Reel/Frame 023032/0774 →
SECURITY AGREEMENT Recorded Mar 26, 2009
From: METACURE LIMITED
To: MEDINVEST CAPITAL S.A R.L.; MORGAN STANLEY BANK INTERNATIONAL LIMITED
Reel/Frame 022449/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2009
From: BEN-HAIM, SHLOMO; DARVISH, NISSIM; MIKA, YUVAL; FENSTER, MAIER; FELZEN, BELLA; SHEMER, ISAAC
To: IMPULSE DYNAMICS N.V.
Reel/Frame 022290/0823 →
CHANGE OF NAME Recorded Feb 20, 2009
From: METACURE N.V.
To: METACURE LIMITED
Reel/Frame 022288/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2009
From: IMPULSE DYNAMICS NV
To: METACURE NV
Reel/Frame 022291/0094 →